dc.contributor.author | PRATAMA, Antonius Nugraha Widhi | |
dc.contributor.author | MUHAROMA, Tri Rizqi | |
dc.contributor.author | KIBTHIYYAH, Mariatul | |
dc.contributor.author | SUBAGIJO, Prihwanto Budi | |
dc.contributor.author | TAN, Elizabeth Yu | |
dc.date.accessioned | 2020-09-30T03:03:18Z | |
dc.date.available | 2020-09-30T03:03:18Z | |
dc.date.issued | 2020-02-01 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/101053 | |
dc.description.abstract | Context: Indonesia is one of countries with staggering number of elderly
population. This population is at risk having comorbidities, polypharmacy,
inappropriate medication, and adverse drug reactions. Aims: This study aimed to
determine the prevalence of Potentially Inappropriate Medications (PIM) and
Potentially Prescription Omissions (PPO) among ambulatory geriatric patients.
Settings and Design: The research was conducted in an internal medicine clinic of a
hospital in Jember Regency, East Java, Indonesia using a retrospective, cross–
sectional design. Methods and Material: Data were collected consecutively with a
targeted sample size of 96 patients during September 2016. Each patient data was
traced back for a minimum of three mo period. Analysis of drugs with PIM and PPO
was based on criteria of the Screening Tool of Older Person's Prescription (STOPP)
and Screening Tool to Alert to Right Treatment (START) version 2. Statistical
analysis used: Descriptive statistics were used to report the results. Results: The
results showed that a total of 92 PIM events occured in 64 patients (64 %) and were
found more in females (66 %), aged 65 yr to 69 yr (70 %) with glimepiride and
pioglitazone as the first and second leading drugs causing PIM events. All eight
PPOs were in the form of not giving antihypertensive therapy to hypertensive
patients according to the START criteria. Conclusions: In conclusion, the PIM
figures were large, while the PPO was small and narrowed to one problem.
Increasing alertness and caution in administering drug therapy will be very
necessary to reduce adverse drug reactions in geriatric patients. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Annals of Tropical Medicine & Public Health, February 2020. 23(3A) | en_US |
dc.subject | Ambulatory patient | en_US |
dc.subject | drug evaluation | en_US |
dc.subject | elderly | en_US |
dc.subject | potentially inappropriate medication | en_US |
dc.subject | potentially prescription omission | en_US |
dc.title | STOPP/START Analysis of Ambulatory Geriatric Patients Attending an Internal Medicine Clinic in Jember, Indonesia | en_US |
dc.type | Article | en_US |
dc.identifier.kodeprodi | kodeprodi2210101#Farmasi | |
dc.identifier.nidn | NIDN0003098302 | |